Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Lets try & stay on topic, this is a great and detailed repor

<< Previous

Bullboard Posts

Next >>

Comment by fox7mfon Oct 20, 2023 12:33pm

117 Views

Post# 35693241

RE:RE:Lets try & stay on topic, this is a great and detailed repor

If updates take a few quarters this will be trading at $0.25. The constant drip in SP could be disgruntled shareholders who piled in after PanCan news and who are frustrated with the lack of business execution & missed deadlines. We can't always attribute a negative day to those dastardly MM's. As for FUD...Coffey creates enough of that on his own.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China